NO954717L - Anti-kolesterolemi egg, vaksine, fremgangsmåte for fremstilling derav og anvendelse - Google Patents

Anti-kolesterolemi egg, vaksine, fremgangsmåte for fremstilling derav og anvendelse

Info

Publication number
NO954717L
NO954717L NO954717A NO954717A NO954717L NO 954717 L NO954717 L NO 954717L NO 954717 A NO954717 A NO 954717A NO 954717 A NO954717 A NO 954717A NO 954717 L NO954717 L NO 954717L
Authority
NO
Norway
Prior art keywords
eggs
warm
directed
blooded animals
bacterial antigens
Prior art date
Application number
NO954717A
Other languages
English (en)
Other versions
NO954717D0 (no
Inventor
Ralph J Stolle
Lee R Beck
Original Assignee
Stolle Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22073631&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO954717(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stolle Res & Dev filed Critical Stolle Res & Dev
Publication of NO954717D0 publication Critical patent/NO954717D0/no
Publication of NO954717L publication Critical patent/NO954717L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L15/00—Egg products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Husbandry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Oppfinnelsen vedrører behandlingen av vaskulære forstyrrelser, særlig arteriosklerose og aterosklerose i varmblodsdyr. Opp- finnelsen omfatter at egg eller eggfraksjoner avledet fra fjærfe av hunnkjønn som er blitt hyperimmunisert med spesi- fikke bakterieantigener eller grupper av bakterieantigener, inntas av varmblodsdyr. Oppfinnelsen vedrører også metoder for å kontrollere kolesterolnivåer, lipidavleiringer og ut- viklingen av ateromatøse lesjoner i varmblodsdyr ved inntak av egg eller fraksjoner derav dannet i fjærfe av hunnkjønn som er hyperimmunisert med spesifikke bakterieantigener. Oppfin- nelsen vedrører også metoder for å fremstille egg og ennvidere vaksiner for hyperimmunisering av fjærfe av hunnkjønn.
NO954717A 1993-05-26 1995-11-22 Anti-kolesterolemi egg, vaksine, fremgangsmåte for fremstilling derav og anvendelse NO954717L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6708893A 1993-05-26 1993-05-26
PCT/US1993/005198 WO1994027623A1 (en) 1993-05-26 1993-05-28 Anti-cholesterolemic egg, vaccine and method for production, and use

Publications (2)

Publication Number Publication Date
NO954717D0 NO954717D0 (no) 1995-11-22
NO954717L true NO954717L (no) 1996-01-26

Family

ID=22073631

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954717A NO954717L (no) 1993-05-26 1995-11-22 Anti-kolesterolemi egg, vaksine, fremgangsmåte for fremstilling derav og anvendelse

Country Status (14)

Country Link
EP (1) EP0707485B1 (no)
JP (1) JPH09500870A (no)
AT (1) ATE216249T1 (no)
AU (1) AU690521B2 (no)
BR (1) BR9307851A (no)
CA (1) CA2163737A1 (no)
DE (1) DE69331836T2 (no)
DK (1) DK0707485T3 (no)
ES (1) ES2177546T3 (no)
FI (1) FI955692A (no)
IL (1) IL105845A0 (no)
NO (1) NO954717L (no)
NZ (1) NZ254326A (no)
WO (1) WO1994027623A1 (no)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4357272A (en) * 1978-03-22 1982-11-02 The South African Inventions Development Corporation Recovering purified antibodies from egg yolk
JPS57144215A (en) * 1981-03-02 1982-09-06 Nippon Nousan Kogyo Kk Composition for improving lipometabolism
US4748018A (en) * 1984-02-07 1988-05-31 Stolle Research & Development Corp. Method of passive immunization of mammals using avian antibody
US5215746A (en) * 1982-06-03 1993-06-01 Stolle Research And Development Corporation Anti-cholesterolemic egg, vaccine and method for production, and use
US4636384A (en) * 1982-06-03 1987-01-13 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
JPH0651632B2 (ja) * 1985-09-05 1994-07-06 昭和産業株式会社 降コレステロ−ル剤

Also Published As

Publication number Publication date
EP0707485A1 (en) 1996-04-24
CA2163737A1 (en) 1994-12-08
BR9307851A (pt) 1996-03-19
JPH09500870A (ja) 1997-01-28
IL105845A0 (en) 1993-12-28
DE69331836T2 (de) 2002-08-22
FI955692A (fi) 1996-01-24
ATE216249T1 (de) 2002-05-15
FI955692A0 (fi) 1995-11-24
EP0707485B1 (en) 2002-04-17
AU4597993A (en) 1994-12-20
NO954717D0 (no) 1995-11-22
AU690521B2 (en) 1998-04-30
NZ254326A (en) 1998-01-26
ES2177546T3 (es) 2002-12-16
WO1994027623A1 (en) 1994-12-08
DE69331836D1 (de) 2002-05-23
DK0707485T3 (da) 2002-08-26

Similar Documents

Publication Publication Date Title
NO931372D0 (no) Behandling av autoimmunsykdommer ved oral administrering av autoantigener
IL142691A (en) Use of an antibody which binds to ailim protein in the manufacture of medicament for preventing, treating or prophylaxis of graft versus host reaction
EA200000608A1 (ru) Предотвращение и лечение амилоидогенного заболевания
ES500567A0 (es) Procedimiento de preparar complejos vacunantes por reaccion de arn ribonosales y de antigenos especificos.
DE69733145D1 (de) Verfahren zur behandlung von allergischen lungenkrankheiten
EP0301992A3 (en) Vaccine against group B Neisseria meningitidis, gammaglobulin and transfer factor.
DE69332518D1 (de) Unterdrückung von autoimmunkrankheiten durch antigene in wartestellung
GB2247837A (en) Pharmaceutical product for the treatment of immunoregulatory disorders
EP0313378A3 (en) Methods and compositions for transient elimination of humoral immune antibodies
GB8423993D0 (en) Pyridine-soluble extract
ATE166230T1 (de) Verwendung von anti-icam antikörpern zur herstellung eines präparats für die behandlung von endotoxinschock
SE7906793L (sv) Modifierade grespollenantigener och sett for framstellning derav
KR880003632A (ko) 계란으로부터의 특이적항체함유재료 및 그 제조방법과 용도
DE3587681T2 (de) Vakzine und Serum für Endotoxin assoziierte Krankheit und Verfahren zur Herstellung derselben sowie Verfahren zur Immunisierung und Behandlung solcher Krankheiten, enttoxifierte Endotoxine und bakterielle Mutante.
DE69737323D1 (de) Adhesin aus heliobacter pylori, welches an blutgruppenantigene bindet
DK398683D0 (da) Fremgangsmade til fremstilling af antistoffer
NO954717L (no) Anti-kolesterolemi egg, vaksine, fremgangsmåte for fremstilling derav og anvendelse
WO2001049319A8 (de) Zusammensetzung, enthaltend bakterielle antigene, zum vorbeugen und behandeln von allergischen erkrankungen
Vainio et al. Early ontogeny of germinal center formation in the chicken
JP2004506695A5 (no)
DE69025629D1 (de) Arzneimittel und verfahren zur behandlung von erworbenem immundefizienzsyndrom (aids) und aids-verwandtem komplex unter verwendung von karbohydratspezifischen antikörpern
Mukkur et al. Possible immunological synergism among the protective antigens of Pasteurella multocida, type A
Rakszewska et al. Helicobacter pylori infection and arteriosclerosis
Beckham LECITHIN THERAPY FOR TARDIVE DYSKINESIA.
WO2003074003A3 (en) Immunogens for treatment of neoplastic and infectious disease